Works matching IS 2160763X AND DT 2019 AND VI 8 AND IP 6
Results: 15
Correction to: Pharmacokinetics and Bioavailability of a New Testosterone Gel Formulation in Comparison to Testogel® in Healthy Men.
- Published in:
- Clinical Pharmacology in Drug Development, 2019, v. 8, n. 6, p. 844, doi. 10.1002/cpdd.705
- Publication type:
- Article
Pharmacokinetic Properties of Ibuprofen (IBU) From the Fixed‐Dose Combination IBU/Caffeine (400/100 mg; FDC) in Comparison With 400 mg IBU as Acid or Lysinate Under Fasted and Fed Conditions—Data From 2 Single‐Center, Single‐Dose, Randomized Crossover Studies in Healthy Volunteers
- Published in:
- Clinical Pharmacology in Drug Development, 2019, v. 8, n. 6, p. 742, doi. 10.1002/cpdd.672
- By:
- Publication type:
- Article
Drug‐Drug Interactions of Tacrolimus or Cyclosporine With Glecaprevir and Pibrentasvir in Healthy Subjects.
- Published in:
- Clinical Pharmacology in Drug Development, 2019, v. 8, n. 6, p. 779, doi. 10.1002/cpdd.671
- By:
- Publication type:
- Article
A Randomized, Double‐Blind, Placebo‐Controlled, First‐Time‐in‐Human Study to Assess the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Doses of GSK3389404 in Healthy Subjects.
- Published in:
- Clinical Pharmacology in Drug Development, 2019, v. 8, n. 6, p. 790, doi. 10.1002/cpdd.670
- By:
- Publication type:
- Article
Randomized Phase I Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Topical Daprodustat in Healthy Volunteers and in Patients With Diabetic Foot Ulcers.
- Published in:
- Clinical Pharmacology in Drug Development, 2019, v. 8, n. 6, p. 765, doi. 10.1002/cpdd.654
- By:
- Publication type:
- Article
Population Pharmacokinetic Analysis of Daclatasvir, Asunaprevir, and Beclabuvir Combination in HCV‐Infected Subjects.
- Published in:
- Clinical Pharmacology in Drug Development, 2019, v. 8, n. 6, p. 802, doi. 10.1002/cpdd.649
- By:
- Publication type:
- Article
No Effect of Plazomicin on the Pharmacokinetics of Metformin in Healthy Subjects.
- Published in:
- Clinical Pharmacology in Drug Development, 2019, v. 8, n. 6, p. 818, doi. 10.1002/cpdd.648
- By:
- Publication type:
- Article
Effect of Rifampicin on the Pharmacokinetics of a Single Dose of Vemurafenib in Patients With BRAF<sup>V600</sup> Mutation–Positive Metastatic Malignancy.
- Published in:
- Clinical Pharmacology in Drug Development, 2019, v. 8, n. 6, p. 837, doi. 10.1002/cpdd.643
- By:
- Publication type:
- Article
The Effect of a High‐Fat Meal on the Pharmacokinetics of Brigatinib, an Oral Anaplastic Lymphoma Kinase Inhibitor, in Healthy Volunteers.
- Published in:
- Clinical Pharmacology in Drug Development, 2019, v. 8, n. 6, p. 734, doi. 10.1002/cpdd.641
- By:
- Publication type:
- Article
Pharmacokinetics, Safety, and Tolerability Evaluation of Single and Multiple Doses of GSK3342830 in Healthy Volunteers.
- Published in:
- Clinical Pharmacology in Drug Development, 2019, v. 8, n. 6, p. 754, doi. 10.1002/cpdd.637
- By:
- Publication type:
- Article
Single‐Dose Pharmacokinetic Properties and Relative Bioavailability of Different Formulations of Posaconazole Oral Suspension in Healthy Volunteers.
- Published in:
- Clinical Pharmacology in Drug Development, 2019, v. 8, n. 6, p. 827, doi. 10.1002/cpdd.636
- By:
- Publication type:
- Article
Pharmacokinetics of Single and Repeat Doses of Fluticasone Furoate/Umeclidinium/Vilanterol in Healthy Chinese Adults.
- Published in:
- Clinical Pharmacology in Drug Development, 2019, v. 8, n. 6, p. 721, doi. 10.1002/cpdd.626
- By:
- Publication type:
- Article
Bioequivalence of Sarpogrelate in Healthy Chinese Subjects Under Fasting and Fed Conditions: A 4‐Way Replicate Crossover Investigation by a Reference‐Scaled Average Bioequivalence Approach.
- Published in:
- Clinical Pharmacology in Drug Development, 2019, v. 8, n. 6, p. 713, doi. 10.1002/cpdd.624
- By:
- Publication type:
- Article
Relative and Absolute Bioavailability Study of Emicizumab to Bridge Drug Products and Subcutaneous Injection Sites in Healthy Volunteers.
- Published in:
- Clinical Pharmacology in Drug Development, 2019, v. 8, n. 6, p. 702, doi. 10.1002/cpdd.617
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Clinical Pharmacology in Drug Development, 2019, v. 8, n. 6, p. 697, doi. 10.1002/cpdd.594
- Publication type:
- Article